Following the successful incorporation, Wound Innovations has forged ahead by securing a preferred partnering deal with a multi-national healthcare organisation Paul Hartman Pty Ltd (‘HARTMANN’).
Chairman of the Wound Management Innovation Cooperative Research Centre (Wound CRC) Professor Rob Sale commented:
“I am delighted to see this true innovation be brought into reality through a CRC and that entity go on to attract world class partners.
I believe the Wound CRC should be proud that it has created a world first with Wound Innovations and that innovation will be trialled in Australia.
Wound Innovations is a center of excellence for disciplines related to wounds and as such can engage care providers and patients in a way that will empower them and provide better health outcomes for the nation.”
CEO of the Wound Management Innovation Cooperative Research Centre (Wound CRC) and incoming CEO of Wound Innovations, Dr Ian Griffiths, today said:
“We are proud to announce a preferred partnering deal with HARTMANN, as they share our vision for the creation of a National wound organisation which can act independently while meaningfully engaging with industry.
All Australian wound sufferers deserve the best research-based treatment. This can be achieved in a systematic way and HARTMANN are investing in a number of Wound Innovations collaborative activities including: clinical services, telehealth, education (including online learning), credentialing and research.
We are also continuing negotiations with other complimentary industry partners, as we recognize that multiple organisations together play a role in advancing wound care treatments and products. It is through these partnerships that we are committed to continuing the collaborative journey of the CRC and to translating research to real-world outcomes.”
Managing Director of HARTMANN Australia, Mark Summerville, today stated:
“We are excited to further enhance our partnership with the formation of Wound Innovations. Since joining the Wound CRC as an industry partner we have worked collaboratively to help advance research, treatment and access to wound care in Australia.
Our brand promise is to go further for health and by working closer with Wound Innovations we can help provide services and support that extends beyond our expertise.
Our mission in Wound management is to remove the complexity out of wound care by providing simpler and more integrated solutions for both patients and health care professionals.”
About Wound Innovations
Wound Innovations is dedicated to clinical wound treatment, education and research. We offer a patient-centred service to improve wound outcomes – through our clinic at Spring Hill and nationally via telehealth. Our model of care is truly unique – all consultations are conducted by our inter-disciplinary specialist team in the one location. It is through this approach that access to evidence-based care is accessible to patients nation-wide. We also offer training for health professionals via workshops, online modules and more, to deliver the latest, evidence-based treatment methods and approaches for wound management. Wound Innovations is a spin-off company of the Wound Management Innovation Cooperative Research Centre (Wound CRC) with the support of the Australian Government’s CRC Programme.
About HARTMANN GROUP
The HARTMANN GROUP is one of the leading providers of medical and hygiene products, with its core expertise in wound management, disinfection, incontinence, risk prevention, and personal healthcare. With headquarters in Heidenheim, Germany and group companies worldwide, the company is in close touch with the global market. In 2017, the HARTMANN Group’s 10,764 employees generated sales of 2.06 billion euros. HARTMANN Australia National Support Office is based in Macquarie Park, Sydney, with a focus on continence management, wound management and risk prevention. HARTMANN Australia also has a local TGA certified manufacturing facility based in Mona Vale Sydney, specialising in customised procedure surgical packs.